RE: Accustem listing date??16 Jan 2021 23:01
0161
"I am increasingly becoming of the opinion that Accustem may have been split not to sell, but for the BOD to keep it, as it has value that wouldn't be realised if they sold Tiziana to a mabs focus pharma".
That is exactly the case. It was said in a proactive interview. Not about selling it on to a big pharma but 100% said they split the company into 2 because they realised 2 seperate SPs would be higher than 1 company as a whole.